Mission and Vision
Neuropsychiatric and neurodegenerative diseases of adulthood such as depression, schizophrenia, Parkinson’s disease and motor neuron disease are highly disabling diseases that place an immense burden on individuals, their families and society.
The mission of the research training group (RTG) is to further the development of prevention and treatment strategies for these diseases through a deeper understanding of the underlying pathophysiological mechanisms. To fulfill this mission, basic and clinical neuroscientists will combine forces to research the novel key concept that neurodevelopment constitutes a major determinant for the individual’s vulnerability to neuropsychiatric and -degenerative disease in later life. Equally important, the RTG addresses the need to train the next generation of neuroscientists in this important emerging pathophysiological concept.
The members of the RTG envision that the intensive training and research activities will significantly impact on the development of new perspectives for disease prevention and treatment.
Starting from July 2016, the RTG will train PhD and MD students, postdoctoral fellows and medical residents in the complex interplay of neurodevelopment and adult-onset CNS diseases.
Participants will be intensively guided by an interdisciplinary team of experts in basic, clinical and translational neuroscience. The curriculum is tailored to train young researchers in innovative concepts and key scientific skills to prepare them for their career.
Postdoctoral fellows and the first cohort of PhD students will start training in July 2016; MD students will be admitted to the RTG on a rolling basis. Training for medical residents will start in spring 2017 and spring 2019.
PhD student positions in
- Pathophysiology of Psychiatric Disease (PDF)
- Common Genetics of Schizophrenia and Intellectual Disability (PDF)
salary grade: TVL-E13 / 65%, starting date is summer or autumn 2016
Two MD thesis students
6 months stipends available